Study IDs Determinants of the Neuro-Retinal Rim Area

This article originally appeared here.
Share this content:
Study IDs Determinants of the Neuro-Retinal Rim Area
Study IDs Determinants of the Neuro-Retinal Rim Area

THURSDAY, Sept. 14, 2017 (HealthDay News) -- Reduced neuro-retinal rim area (RA) is associated with narrow central retinal venular equivalent (CRVE) and higher intraocular pressure (IOP), according to a study published online Aug. 31 in Clinical & Experimental Ophthalmology.

Qing Zhang, M.D., from Beijing Institute of Ophthalmology, and colleagues conducted comprehensive eye examinations, including fundus photograph-based measurements of retinal vessel diameter and Heidelberg retinal tomogram (HRT) measurement of the optic disc, in 6,830 adults (≥30 years).

The researchers found that after excluding those with high myopia or without gradable HRT images, 4,194 non-glaucoma and 40 primary open-angle glaucoma (POAG) patients were evaluated for determinants of RA. Determinants of reduced RA were POAG (P < 0.001), higher intraocular pressure (P = 0.03), higher refractive error (P < 0.01), longer axial length (P = 0.01), CRVE (P < 0.001), lower body mass index (BMI; P = 0.015), older age (P < 0.001), smaller disc area (P < 0.001), and higher trans-lamina cribrosa pressure difference (P = 0.03). Reduced RA was associated with lower cerebrospinal fluid pressure only when age and/or BMI were omitted from the model (P < 0.001).

"In summary, our population based study shows that a reduced optic disc rim area is significantly associated with narrow CRVE and higher IOP or lower cerebrospinal fluid pressure," the authors write. "It adds to existing knowledge and supports the concept of multiple factors (biomechanical, vascular, and others) acting concurrently in different sufficient component causal models to cause optic nerve damage in POAG."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »